EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access

Updated Treatment of Non‐Steroidal Anti‐Inflammatory Drug‐Exacerbated Respiratory Disease: How to Decide on Aspirin Therapy After Desensitization or Biologics? When? How? An EAACI Task Force Report

Gülfem E Çelik iD, Joanna S Makowska iD, Maria Jose Torres iD, Cristobalina Mayorga iD, Tanya M Laidlaw iD, Alessandra Vultaggio, Sanna Toppila-Salmi iD, Ludger Klimek iD, Aslı Gelincik iD, Annick Barbaud iD, Lene H Garvey iD, Ömür Aydın iD and 2 more

Allergy · 2026

DOI: 10.1111/all.70243 ↗

At a glance

Übersichtsarbeit in Allergy, 2026. Written by Gülfem E Çelik and 13 co-authors. Institution: Department of Chest Disease, Division of Immunology and Allergy, Ankara University School of Medicine, and Private Practice, Ankara, Türkiye. Major MEDLINE topics: Anti-Inflammatory Agents, Non-Steroidal, Desensitization, Immunologic, Aspirin, Biological Products. Cited 4 times so far (Crossref); 122 references. The full text is freely available in PubMed Central. Funded by: European Academy of Allergy and Clinical Immunology.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Nonsteroidal anti‐inflammatory drug (NSAID)‐exacerbated respiratory disease (NSAID‐ERD) is a heterogeneous condition characterized by chronic eosinophilic airway inflammation in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma whose symptoms are aggravated after ingestion of aspirin and other NSAIDs. As a unique treatment, aspirin treatment after desensitization (ATAD) has been in use for several years after showing the inhibitory effect on CRS symptoms and nasal polyp growth as well as severe asthma. However, in recent years, biologics have also shown to cause a decrease in polyp size as well as associated outcomes such as quality of life. In this manuscript, considerations on choosing the best treatment of NSAID–ERD are laid out based on current literature.

Subjects

MeSH terms (MEDLINE)

Anti-Inflammatory Agents, Non-SteroidalDesensitization, ImmunologicAspirinBiological ProductsAsthma, Aspirin-InducedRespiratory Tract DiseasesHumansTreatment OutcomeRhinosinusitisNasal Polyps

Author keywords

NSAIDs exacerbated respiratory diseaseaspirin desensitizationaspirin exacerbated respiratory diseaseaspirin treatment after desensitizationasthmabiologicschronic rhinosinusitis with nasal polyps (CRSwNP)endoscopic sinus surgery

Substances

Anti-Inflammatory Agents, Non-SteroidalAspirinBiological Products

Authors and institutions

  • Department of Chest Disease, Division of Immunology and Allergy, Ankara University School of Medicine, and Private Practice, Ankara, Türkiye.
  • Department of Rheumatology and Clinical Immunology, Medical University of Lodz, Lodz, Poland.
  • Allergy Research Group, IBIMA Plataforma BIONAND, Málaga, Spain.
  • Departamento de Medicina, Universidad de Málaga-UMA, Málaga, Spain.
  • Allergy Unit, Hospital Regional Universitario de Málaga and IBIMA Plataforma BIONAND, Málaga, Spain.
  • RICORS Red De Enfermedades Inflamatorias (REI), Madrid, Spain.

ORCID profiles: Gülfem E Çelik, Joanna S Makowska, Maria Jose Torres, Cristobalina Mayorga, Tanya M Laidlaw, Sanna Toppila-Salmi, Ludger Klimek, Aslı Gelincik, Annick Barbaud, Lene H Garvey, Ömür Aydın, Thomas Eiwegger, Katharine M Woessner

Funding

  • European Academy of Allergy and Clinical Immunology

Cite

APA

Çelik, G. E., Makowska, J. S., Torres, M. J., Mayorga, C., Laidlaw, T. M., Vultaggio, A., Toppila-Salmi, S., Klimek, L., Gelincik, A., Barbaud, A., Garvey, L. H., Aydın, Ö., Eiwegger, T., & Woessner, K. M. (2026). Updated Treatment of Non‐Steroidal Anti‐Inflammatory Drug‐Exacerbated Respiratory Disease: How to Decide on Aspirin Therapy After Desensitization or Biologics? When? How? An EAACI Task Force Report. Allergy. https://doi.org/10.1111/all.70243

Vancouver

Çelik GE, Makowska JS, Torres MJ, Mayorga C, Laidlaw TM, Vultaggio A, et al. Updated Treatment of Non‐Steroidal Anti‐Inflammatory Drug‐Exacerbated Respiratory Disease: How to Decide on Aspirin Therapy After Desensitization or Biologics? When? How? An EAACI Task Force Report. Allergy. 2026. doi:10.1111/all.70243

BibTeX
@article{elik2026,
  author = {Çelik, Gülfem E and Makowska, Joanna S and Torres, Maria Jose and Mayorga, Cristobalina and Laidlaw, Tanya M and Vultaggio, Alessandra and Toppila-Salmi, Sanna and Klimek, Ludger and Gelincik, Aslı and Barbaud, Annick and Garvey, Lene H and Aydın, Ömür and Eiwegger, Thomas and Woessner, Katharine M},
  title = {Updated Treatment of Non‐Steroidal Anti‐Inflammatory Drug‐Exacerbated Respiratory Disease: How to Decide on Aspirin Therapy After Desensitization or Biologics? When? How? An EAACI Task Force Report},
  journal = {Allergy},
  year = {2026},
  doi = {10.1111/all.70243}
}
Start for free →